A Comparative Clinical Study Of two oral drugs Shatapushpa Churṇa And Chaturbeeja Churṇa In The Management Of PCOS Polycystic Ovarian Syndrome
- Conditions
- Health Condition 1: N91- Absent, scanty and rare menstruation
- Registration Number
- CTRI/2019/04/018364
- Lead Sponsor
- ational Institute of Ayurveda Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Presence of any two of the following three criteria
Patients age 18 â?? 45 years and (ASRM/ESHRE,2003)
Oligo and /or anovulation
Hyper-androgenism(clinical and /or biochemical).
Polycystic ovaries.
Pregnant women.
Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, chronic renal disease, uncontrolled diabetes mellitus etc.).
Patients using oral contraceptive pills.
Patients with any organic reproductive system abnormalities (Excluded clinically and radiologically), pelvic inflammatory disease, hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ..
Any type of malignancy.
Positive STDs, HIV, HBsAg.
Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relief in symptoms of PCOSTimepoint: relief in symptoms in 60 days
- Secondary Outcome Measures
Name Time Method relief from PCOSTimepoint: 60 days